SANA: Clinical milestones for diabetes and CAR T therapies are on track, with key trials imminent
Significant progress was highlighted for both the type 1 diabetes and in vivo CAR T platforms, with key clinical milestones expected in the next 12 months. Strategic collaboration with Mayo Clinic is accelerating trial readiness, and first-in-human data for lead CAR T program is anticipated in 2027…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.